Important Announcements

Nondiscrimination Statement Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To see our full nondiscrimination statement, click here.

Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

Project TRUST


617.680.1828

Project TRUST’s goal is to help anyone who is actively struggling with substance use access comprehensive and compassionate care without judgement. We provide addiction treatment resources, harm reduction education and supplies, and navigation to an array of medical services including primary care and urgent care services. The Project TRUST team is made up of compassionate community health workers, who use their lived experience to guide people in active addiction. The Project TRUST drop-in was started in 1988 in response to the first wave of HIV in Boston among persons who use injection drugs. We have continued with our mission to provide comprehensive services that stop the transmission of infectious diseases in those who struggle with substance use.

Contact Us

721 Massachusetts Avenue, Boston, MA 02118
617.680.1828

Research Overview

Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report. - Harris M, Johnson S, Mackin S, Saitz R, Walley AY, Taylor JL.  J Addict Med. 2020;14(4):e136-e138. doi:10.1097/ADM.0000000000000682

Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment - Taylor JL, Johnson S, Cruz R, Gray JR, Schiff D, Bagley SM. [published online ahead of print, 2021 Jun 22]. J Gen Intern Med. 2021;1-10. doi:10.1007/s11606-021-06904-4

Partnering With State Health Departments to Address Injection-Related Infections During the Opioid Epidemic: Experience at a Safety Net Hospital. - Burns RH, Pierre CM, Marathe JG, et al.  Open Forum Infect Dis. 2021;8(8):ofab208. Published 2021 Apr 27. doi:10.1093/ofid/ofab208

Residency and Fellowship Information

Addiction Medicine Fellowship

The mission of the Grayken Fellowship in Addiction Medicine is to train physician addiction medicine leaders in clinical care, research, education, public health, and advocacy to improve addiction care for people vulnerable to health inequities due to race, ethnicity, gender, poverty, age, disability or stigmatizing illness.

The Grayken Addiction Medicine Fellowship Program is a 1 or 2 year fellowship. There is also a 3-year combined Infectious Disease-Addiction Medicine Fellowship and a 2-year Fellowship in Maternal Health Addiction. Fellows are mentored by our multidisciplinary faculty from Internal Medicine, Infectious Disease, Emergency Medicine, Obstetrics & Gynecology and Addiction Psychiatry. The Grayken Fellowship in Addiction Medicine is accredited by the ACGME. Click here to learn more